Document is current

Trial-level analysis of progression-free survival and response rate as end points of trials of first-line chemotherapy in advanced ovarian cancer

Crossref DOI link: https://doi.org/10.1007/s12032-017-0939-9

Published Online: 2017-04-08

Published Print: 2017-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy